Bristol Myers Squibb Announces Quarterly Dividend of $0.63

The biopharmaceutical company will pay shareholders a 4.2% yield on May 1st.

Mar. 31, 2026 at 11:19am

Got story updates? Submit your updates here. ›

A highly detailed, macro-level view of the complex mechanical components and gears that power the banking industry, conveying a sense of the institutional strength and reliability behind Bristol Myers Squibb's dividend program.An extreme close-up of the intricate inner workings of the financial system illustrates the stability and security behind Bristol Myers Squibb's consistent dividend payouts.Princeton Today

Bristol Myers Squibb Company (NYSE:BMY) declared a quarterly dividend of $0.63 per share on Monday, March 2nd. Shareholders of record on Thursday, April 2nd will receive the dividend on Friday, May 1st. This represents a 4.2% yield on an annualized basis.

Why it matters

Bristol Myers Squibb has a strong history of raising its dividend, having increased it every year for the past 17 years. The company's dividend payout ratio of 41.5% indicates the dividend is well-covered by earnings, providing stability for income-focused investors.

The details

The ex-dividend date for the $0.63 per share dividend is Thursday, April 2nd. Bristol Myers Squibb has raised its dividend by an average of 0.0% per year over the last three years. Analysts expect the company to earn $6.09 per share in the next fiscal year, which would allow it to continue covering the $2.52 annual dividend with a payout ratio of 41.4%.

  • Bristol Myers Squibb declared the quarterly dividend on Monday, March 2nd, 2026.
  • The dividend will be paid on Friday, May 1st, 2026 to shareholders of record on Thursday, April 2nd, 2026.
  • The ex-dividend date is Thursday, April 2nd, 2026.

The players

Bristol Myers Squibb Company

A global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing and delivering medicines for serious diseases.

Got photos? Submit your photos here. ›

The takeaway

Bristol Myers Squibb's consistent dividend growth and healthy payout ratio make it an attractive option for income-oriented investors seeking stability in the healthcare sector.